Universal Health Services, Inc. reported strong Q3 2024 results, with net revenues increasing by 11.2% to $3.963 billion and net income attributable to UHS reaching $258.7 million, or $3.80 per diluted share, compared to $167.0 million, or $2.40 per diluted share, in Q3 2023. Adjusted net income was $252.5 million, or $3.71 per diluted share. EBITDA net of NCI was $528.6 million, representing 13.3% of net revenues.
Net revenues increased by 11.2% to $3.963 billion compared to Q3 2023.
Net income attributable to UHS was $258.7 million, or $3.80 per diluted share.
Adjusted net income attributable to UHS was $252.5 million, or $3.71 per diluted share.
EBITDA net of NCI was $528.6 million, or 13.3% of net revenues.
UHS did not provide forward guidance in the Q3 2024 earnings report.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance